TaxMasters, Inc. (OTCBB: TAXS)
Employer Support of the Guard and Reserve (ESGR) awarded TaxMasters, Inc. the IRS tax relief company, with a Pro Patria Award on Thursday, March 25, 2010. Mr. Cox and Vice President of Sales Alex Clamon attended the ESGR Awards Banquet in Austin, Texas, as part of the National Guard Association of Texas Annual Conference. Already recognized as a Patriotic Employer by ESGR, TaxMasters was one of six public and private companies in Texas chosen for a Pro Patria Award in 2010. Each ESGR Committee presents this award annually to employers in their state or territory who have exercised leadership and implemented exceptional personnel policies that accommodate employees who serve in the National Guard and Reserve.
About TaxMasters, Inc.
TaxMasters, Inc., the IRS tax relief company, is the first publicly traded tax resolution firm in the United States. Started by Patrick R. Cox in 2001, TaxMasters offers services and counsel to taxpayers across the country facing seemingly insurmountable tax problems, and relief from substantial federal tax debt.
Employing over 300 people, TaxMasters leverages the expertise of ex-IRS agents, enrolled agents, attorneys, CPAs, and seasoned tax consultants ready to counsel and assist every day people with their specific tax problems today.
Visit TaxMasters, Inc. (TAXS.OB) for more information at www.txmstr.com
Power3 Medical Products, Inc. (OTCBB: PWRM)
The Company has signed a definitive agreement to acquire all of the stock of StemTroniX Inc., a Texas corporation (”StemTroniX”). Power3 plans to effectuate the acquisition of StemTroniX by merging a wholly-owned subsidiary of the Company with and into StemTroniX. StemTroniX will remain as the surviving company in the merger and will become a wholly-owned subsidiary of Power3. The acquisition of StemTroniX is expected to be completed in April 2010.
About Power3 Medical Products, Inc.
Power3 Medical Products, Inc.(PWRM.OB) is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets, and its diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas and continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS, Alzheimer’s, and Parkinson’s diseases, breast cancer, and drug resistance.
Visit Power 3 Medical Products Inc. (PWRM.OB) for more information at www.Power3Medical.com
Cavitation Technologies, Inc. (OTCBB: CVAT)
has signed an agreement with Catalyst Partners, LLC located in Washington, D.C. CVAT will be working primarily with Dr. David McWhorter, Principal. Catalyst Partners will strive to open doors within the Government, identify Federal contracts, and help CVAT gain exposure with major US Corporations, which includes raising awareness of CVAT’s technology in various industries.
BioForce 9000 (biodiesel technology) is a fully-automated system that performs complete transesterification fully converting all mono, di, and tri-glycerides contained in feedstock (such as animal fats and vegetable oils) into methyl esters (biodiesel). (CLICK IMAGE TO VIEW)
About Cavitation Technologies, Inc.
Cavitation Technologies, Inc. is a “Green-Tech” company, established in 2006 to become a world leader in the development of new cutting edge technologies for the vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, food and beverage, and chemical industries.
Visit Cavitation Technologies, Inc. (CVAT.OB) for more information at www.cavitationtechnologies.com
***************************ADVERTISEMENTS**************************
.png)
.png)
.png)
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received twenty four thousand dollars from Tax Masters Inc.(TAXS.OB) for 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has received four thousand dollars from a third party (Marshall Curtis) for 30 days of advertisement for services for Tax Masters Inc.(TAXS.OB) which has expired. Crown Equity Holdings, Inc. has received an additional four thousand dollars from the same third party (Marshall Curtis) for an additional 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and disseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings, Inc. (CRWE.OB) anticipates receiving sixty thousand dollars in 144 restricted stock for twelve months of advertisement services for Cavitation Technologies, Inc. (CVAT.OB)
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
taxs_pennyotcstock1 pwrm_pennyotcstock1 cvat_pennyotcstock1
March 31st, 2010 
The News Desk 
